Corticosteroids

Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis
Stéphane Hilliquin, Benjamin Hugues, Stéphane Mitrovic, Laure Gossec, Bruno Fautrel

Annals of the Rheumatic Diseases Aug 2018, 77 (8) 1099-1106; DOI: 10.1136/annrheumdis-2017-212612
Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire
Joanna C Robson, Jill Dawson, Helen Doll, Peter F Cronholm, Nataliya Milman, Katherine Kellom, Susan Ashdown, Ebony Easley, Don Gebhart, Georgia Lanier, John Mills, Jacqueline Peck, Raashid Ahmed Luqmani, Judy Shea, Gunnar Tomasson, Peter A Merkel

Annals of the Rheumatic Diseases Aug 2018, 77 (8) 1157-1164; DOI: 10.1136/annrheumdis-2017-212713
Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis
Mascha Koenen, Stephan Culemann, Sabine Vettorazzi, Giorgio Caratti, Lucien Frappart, Wolfgang Baum, Gerhard Krönke, Ulrike Baschant, Jan P Tuckermann

Annals of the Rheumatic Diseases Jul 2018, annrheumdis-2017-212762; DOI: 10.1136/annrheumdis-2017-212762
Sialendoscopy enhances salivary gland function in Sjögren’s syndrome: a 6-month follow-up, randomised and controlled, single blind study
K Hakki Karagozoglu, Arjan Vissink, Tim Forouzanfar, Henk S Brand, Floor Maarse, Derk Hendrik Jan Jager

Annals of the Rheumatic Diseases Jul 2018, 77 (7) 1025-1031; DOI: 10.1136/annrheumdis-2017-212672
Intramuscular glucocorticoid injection versus placebo injection in hip osteoarthritis: a 12-week blinded randomised controlled trial
Desirée M J Dorleijn, Pim A J Luijsterburg, Max Reijman, Margreet Kloppenburg, Jan A N Verhaar, Patrick J E Bindels, Pieter Koen Bos, Sita M A Bierma-Zeinstra

Annals of the Rheumatic Diseases Jun 2018, 77 (6) 875-882; DOI: 10.1136/annrheumdis-2017-212628
Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
Joan T Merrill, William R Shanahan, Morton Scheinberg, Kenneth C Kalunian, David Wofsy, Renee S Martin

Annals of the Rheumatic Diseases Jun 2018, 77 (6) 883-889; DOI: 10.1136/annrheumdis-2018-213032
Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids
Jun Won Park, Jeffrey R Curtis, Jinyoung Moon, Yeong Wook Song, Suhnggwon Kim, Eun Bong Lee

Annals of the Rheumatic Diseases May 2018, 77 (5) 644-649; DOI: 10.1136/annrheumdis-2017-211796
Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question
Kevin L Winthrop, John W Baddley

Annals of the Rheumatic Diseases May 2018, 77 (5) 631-633; DOI: 10.1136/annrheumdis-2017-212588
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)
Yoshikazu Nakaoka, Mitsuaki Isobe, Syuji Takei, Yoshiya Tanaka, Tomonori Ishii, Shumpei Yokota, Akira Nomura, Seitaro Yoshida, Norihiro Nishimoto

Annals of the Rheumatic Diseases Mar 2018, 77 (3) 348-354; DOI: 10.1136/annrheumdis-2017-211878
Response to: ‘Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis’ by Lee and Song
Yoshikazu Nakaoka

Annals of the Rheumatic Diseases Feb 2018, annrheumdis-2017-212871; DOI: 10.1136/annrheumdis-2017-212871

Main menu

Corticosteroids

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Corticosteroids

Pages